Skip to main content
Professional Technical In the Industry Vocabulary Test

cytoreductive surgery

Pronunciation: sy-toe-ree-DUK-tiv

Surgical procedure aimed at removing as much visible tumor as possible in advanced ovarian cancer.

Full Definition

Cytoreductive surgery, also known as debulking surgery, is a complex surgical procedure performed in patients with advanced ovarian cancer to remove all visible tumor deposits. The goal is to achieve optimal cytoreduction, traditionally defined as residual disease less than 1 cm in diameter, though complete gross resection (no visible residual disease) is now the preferred endpoint. The procedure may involve resection of multiple organs including bowel, diaphragm, spleen, and liver surfaces depending on the extent of disease. Primary cytoreduction is performed at initial diagnosis, while interval cytoreduction follows neoadjuvant chemotherapy. The extent of cytoreduction is a major prognostic factor for survival.

Usage

Usage note: Specify 'primary' or 'interval' when applicable to clarify timing relative to chemotherapy.

In Context

  • "Optimal cytoreductive surgery was achieved with no gross residual disease." — Operative report
  • "Neoadjuvant chemotherapy followed by interval cytoreductive surgery is an acceptable treatment approach." — Treatment protocol

Also known as

debulking surgery tumor reductive surgery

Contrasted with

biopsy only

Don't confuse with

staging surgery

Editors from these organizations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON